Torsades de pointes upon fluconazole administration in a patient with acute myeloblastic leukemia

Am J Hematol. 2006 May;81(5):366-9. doi: 10.1002/ajh.20557.

Abstract

Prolonged QT syndrome often causes torsades de pointes (Tdp), a potentially lethal arrhythmia. A 55-year-old woman with M4Eo who was receiving consolidation chemotherapy had an episode of prolonged QT and Tdp following fluconazole (FCZ) administration. Intravenous supplementation of magnesium sulfate and multiple attempts at electrocardioversion led to recovery from the arrhythmia. FCZ appears to contribute to the development of QT prolongation, in particular with low concentrations of serum potassium or magnesium. Although mechanisms of Tdp development in patients with QT prolongation remain to be determined, it is possible that FCZ administration leads to manifestation of Tdp. Special cautions should be exercised upon the emergence of QT prolongation following FCZ administration.

Publication types

  • Case Reports

MeSH terms

  • Antifungal Agents / administration & dosage
  • Antifungal Agents / adverse effects*
  • Antifungal Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Female
  • Fluconazole / administration & dosage
  • Fluconazole / adverse effects*
  • Fluconazole / therapeutic use
  • Humans
  • Leukemia, Myeloid, Acute / complications*
  • Leukemia, Myeloid, Acute / drug therapy
  • Middle Aged
  • Mycoses / complications
  • Mycoses / drug therapy*
  • Opportunistic Infections / complications
  • Opportunistic Infections / drug therapy*
  • Torsades de Pointes / chemically induced*
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Fluconazole